• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18025
Device Problem Material Twisted/Bent (2981)
Patient Problems Hyperglycemia (1905); Nausea (1970); Chills (2191)
Event Date 07/26/2022
Event Type  Injury  
Event Description
It was reported that the patient had been to the emergency room with hyperglycemia.The patient's blood glucose levels reached 571 mg/dl while wearing the pod between 4 and 24 hours.Symptoms reported include nausea, short of breathe, body aches, feeling very cold and dry heaves.The patient was diagnosed with acute hyperglycemia.The patient was treated with iv (intravenous) drip of fluids and injected her with lispro.The patient was released the same day.The pod was still being worn in the emergency room.It was also discovered that the cannula was bent.
 
Manufacturer Narrative
The device has not been returned/received to date.If the device is received, a supplemental report will be submitted with the investigation results.We are unable to determine if any product condition could have contributed to the reported hospitalization and hyperglycemia.We are unable to confirm the bent cannula or to determine if it could have contributed to the reported hyperglycemia.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including confirming the blue soft cannula is inspected for any damage, communicating with the pdm, deployment, delivering fluid, occlusion detection, and freedom from hazard alarms.
 
Manufacturer Narrative
Correction to d(4): catalog no changed from unavailable to zxp425.Correction to g(5): pma/510(k) # changed from unavailable to k192659.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
michael spears
100 nagog park
acton, MA 01720
9786007000
MDR Report Key15156100
MDR Text Key297141685
Report Number3004464228-2022-13574
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385081120057
UDI-Public(01)20385081120057(11)211202(17)230602(10)L72353
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K192659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/02/2023
Device Model Number18025
Device Catalogue NumberZXP425
Device Lot NumberL72353
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/31/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/02/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age70 YR
Patient SexFemale
-
-